Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 17 studies | 38% ± 15% | |
intestine | 10 studies | 28% ± 10% | |
peripheral blood | 9 studies | 35% ± 14% | |
brain | 7 studies | 33% ± 11% | |
eye | 6 studies | 30% ± 9% | |
uterus | 5 studies | 41% ± 17% | |
liver | 5 studies | 28% ± 4% | |
pancreas | 4 studies | 52% ± 6% | |
kidney | 4 studies | 35% ± 13% | |
placenta | 4 studies | 58% ± 24% | |
adipose | 4 studies | 19% ± 3% | |
breast | 3 studies | 38% ± 4% | |
prostate | 3 studies | 39% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3585.88 | 1445 / 1445 | 100% | 52.43 | 183 / 183 |
ovary | 100% | 3537.07 | 180 / 180 | 100% | 52.52 | 430 / 430 |
pancreas | 100% | 3825.99 | 328 / 328 | 100% | 66.45 | 178 / 178 |
prostate | 100% | 4564.93 | 245 / 245 | 100% | 75.86 | 502 / 502 |
stomach | 100% | 5609.56 | 359 / 359 | 100% | 63.44 | 286 / 286 |
uterus | 100% | 3753.04 | 170 / 170 | 100% | 48.58 | 459 / 459 |
skin | 100% | 5373.55 | 1808 / 1809 | 100% | 96.59 | 472 / 472 |
lung | 100% | 8828.70 | 578 / 578 | 100% | 59.99 | 1154 / 1155 |
kidney | 100% | 5283.84 | 89 / 89 | 100% | 61.49 | 900 / 901 |
thymus | 100% | 4450.68 | 653 / 653 | 100% | 55.61 | 604 / 605 |
intestine | 100% | 4334.28 | 966 / 966 | 100% | 57.11 | 526 / 527 |
liver | 100% | 4114.96 | 226 / 226 | 100% | 66.94 | 405 / 406 |
bladder | 100% | 4876.90 | 21 / 21 | 100% | 53.80 | 502 / 504 |
breast | 100% | 5475.60 | 459 / 459 | 99% | 40.13 | 1109 / 1118 |
adrenal gland | 100% | 6899.97 | 258 / 258 | 99% | 45.67 | 228 / 230 |
brain | 99% | 2203.86 | 2613 / 2642 | 100% | 42.52 | 705 / 705 |
adipose | 100% | 6495.78 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 101.32 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 62.46 | 29 / 29 |
spleen | 100% | 6102.78 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 34.44 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 26.09 | 1 / 1 |
blood vessel | 100% | 5598.49 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 7141.65 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 100% | 3980.11 | 859 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 7711.47 | 926 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035577 | Cellular component | azurophil granule membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | BRI3 |
Protein name | Brain protein I3 Membrane protein BRI3 (Brain protein I3) (pRGR2) |
Synonyms | |
Description | FUNCTION: Participates in tumor necrosis factor-alpha (TNF)-induced cell death . May be a target of Wnt/beta-catenin signaling in the liver . . |
Accessions | ENST00000297290.4 [O95415-1] ENST00000539286.5 [O95415-2] O95415 ENST00000491463.4 I3L1V6 |